Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
410
NCT00302224
A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 28, 2005
Completion: Aug 31, 2006
NCT00304538
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus
Phase: Phase 1
Start: Mar 31, 2006
Completion: Jul 31, 2006
NCT00494663
A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
Phase: Phase 2
Start: Jul 31, 2007
Completion: Dec 31, 2008
NCT00622089
Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients
Phase: Phase 2/3
Start: Jan 31, 2008